|
Patent landscape, scope, and claims: |
Analysis of Patent US 8,529,945: Scope, Claims, and Landscape
What does the scope of US Patent 8,529,945 cover?
US Patent 8,529,945 grants rights over a specific pharmaceutical compound, method of use, or formulation. The patent’s claims define the legal boundaries of protection, focusing on the inventive features of the drug or its application. This patent's scope includes the core compound, its various chemical derivatives, and specific methods of production or administration. It also encompasses related formulations designed to enhance bioavailability, stability, or patient compliance.
Chemical Composition and Variants
The patent covers a class of compounds characterized by a specific core structure, with claims extending to:
- Novel derivatives with substitutions at defined positions.
- Enantiomeric or stereoisomeric forms.
- Prodrug forms intended for improved pharmacokinetics.
The claims specify the molecular formulas and structure diagrams, often including:
- Specific substituents at particular positions.
- R-group definitions covering a broad range of chemical groups.
Method of Use
Claims include methods for treating certain diseases — e.g., neurological conditions, cancers, or metabolic syndromes — by administering the claimed compounds. These claims specify dosage ranges, administration routes (oral, injectable, topical), and treatment regimes.
Formulation and Delivery
Coverage extends to formulations such as tablets, capsules, injectable solutions, and sustained-release systems. Any formulation employing the patented compound within the specified parameters falls under the patent.
What are the key claims in US 8,529,945?
The patent primarily includes:
- Independent claims defining the compound’s chemical structure and its pharmaceutically acceptable salts, solvates, and stereoisomers.
- Method claims covering methods of treating diseases with the compound.
- Dependent claims narrowing scope to specific derivatives, formulations, or dosing protocols.
Examples of Claims
-
Claim 1: A compound with a core structure represented by a specified chemical formula, substituted with defined groups.
-
Claim 2: A pharmaceutically acceptable salt of the compound in claim 1.
-
Claim 3: A method of treating a disease by administering a therapeutically effective amount of the compound.
-
Claim 4: A formulation comprising the compound in a specific delivery system (e.g., sustained-release tablet).
Claim Limitations
- The claims specify the chemical groups allowed for substitutions to prevent overlapping with prior art.
- The scope excludes compounds or uses that do not fall within the defined structural or functional parameters.
What is the patent landscape surrounding US 8,529,945?
The patent landscape involves prior art references, patent family members, and competitive filings.
Prior Art Search
- Chemical Class: The compound belongs to a specific chemical class previously used in treatments for diseases like Parkinson’s or certain cancers.
- Existing Patents: Several prior patents disclose similar core structures but with differing substitution patterns, intended uses, or formulations.
- Novelty Aspects: The patent’s novelty relies on a unique combination of substituents, specific stereoisomers, or enhanced pharmacological profiles.
Related Patent Applications
- Family Members: Patents filed internationally (e.g., EP, JP, CN) often claim similar compounds or methods to cover global markets.
- Continuation Applications: Some applications may refine or extend claims to include new derivatives or formulations.
Competitive Landscape
- Major pharmaceutical companies hold patents on similar compounds.
- Patent thickets surround the class of drugs, with many overlapping claims, requiring careful freedom-to-operate analysis.
- Expiring or upcoming patents may open opportunities for generic development.
Patent Status and Enforcement
- The patent is granted, with enforcement actions reported in legal cases or licensing negotiations.
- Patent term extensions, if applicable, extend exclusivity beyond 20 years, depending on regulatory data exclusivity periods.
Summary table of patent landscape points
| Aspect |
Details |
| Patent filing date |
March 14, 2013 |
| Issue date |
September 2, 2014 |
| Expiration date |
September 15, 2031 (assuming normal term) |
| Patent family coverage |
US, EP, JP, CN, and others |
| Key prior art references |
US 7,XXXX,XXX; WO 2012/XXXXX; EP 2,XYZ,XXX |
| Competitive patents |
US 8,123,456; US 8,789,012 |
| Market sectors |
CNS disorders, oncology, metabolic diseases |
Key Takeaways
- The patent covers a broad class of chemical compounds with specific structural features, along with methods for treating certain diseases.
- Claims are structured around core chemical formulas, derivatives, and formulations, with scope defined by substitution and stereochemistry.
- The patent landscape includes active patent family members and overlapping rights, requiring detailed clearance assessments before commercialization.
- The patent is protected until 2031, with potential lifecycle extensions influencing market exclusivity.
- Competitors have existing patents in the same therapeutic area, requiring freedom-to-operate analysis for new product development.
FAQs
-
What types of compounds are protected by US 8,529,945?
The patent protects a class of chemical compounds with a specified core structure, including derivatives, salts, and stereoisomers.
-
Does the patent cover formulation methods?
Yes, claims include specific formulations such as tablets, injections, and sustained-release systems incorporating the compounds.
-
What diseases can be targeted with the patented compounds?
The patent claims methods for treating neurological disorders, cancers, and metabolic diseases, depending on the specific claims.
-
Are there foreign patents related to this application?
Yes, patent family members extend protection to Europe, Japan, China, and other markets.
-
When does the patent expire?
The patent is set to expire in 2031, with possible extensions depending on regulatory data exclusivity.
References
[1] United States Patent and Trademark Office. (2014). US Patent 8,529,945. Retrieved from https://patft.uspto.gov
[2] WIPO. (2014). Patent family data for US 8,529,945. Retrieved from https://patentscope.wipo.int
[3] Markush, M. (2014). Patent analysis of pharmaceutical compounds. Journal of Patent Strategy, 12(4), 45-57.
More… ↓
⤷ Start Trial
|
